Markvicka Taunia
Insider CIK 1545282 · STAB Chief Operating Officer, Director · PCRX Vice President, Commercial · CRMD Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| STAB Statera Biopharma, Inc. | A Award | 2021-09-28 | 2021-09-30 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CRMD CorMedix Inc. | P Buy | 2017-05-15 | 2017-05-17 | 14,500 | $0.51 | $7.4K | 37,100 | SEC↗ |
| CRMD CorMedix Inc. | A Award deriv | 2017-02-21 | 2017-02-23 | 13,571 | — | $0 | 13,571 | SEC↗ |
| CRMD CorMedix Inc. | A Award deriv | 2017-02-21 | 2017-02-23 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CRMD CorMedix Inc. | P Buy | 2016-08-25 | 2016-08-29 | 18,600 | $1.65 | $30.7K | 22,600 | SEC↗ |
| CRMD CorMedix Inc. | A Award deriv | 2016-02-22 | 2016-02-24 | 90,000 | $1.91 | $171.9K | 90,000 | SEC↗ |
| CRMD CorMedix Inc. | P Buy | 2015-06-23 | 2015-06-25 | 4,000 | $4.81 | $19.2K | 4,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2015-03-17 | 2015-03-19 | 8,349 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2015-03-17 | 2015-03-19 | 8,349 | $5.49 | $45.8K | 8,579 | SEC↗ |
| CRMD CorMedix Inc. | A Award deriv | 2015-03-02 | 2015-03-03 | 50,000 | $5.62 | $281.0K | 50,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | P Buy | 2014-11-07 | 2014-11-12 | 230 | $86.62 | $19.9K | 230 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2014-06-03 | 2014-06-05 | 70,000 | — | $0 | 70,000 | SEC↗ |
| CRMD CorMedix Inc. | A Award deriv | 2014-04-04 | 2014-04-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2013-11-06 | 2013-11-08 | 50,000 | — | $0 | 100,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-11-06 | 2013-11-08 | 14,123 | $51.36 | $725.4K | 7,483 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-11-06 | 2013-11-08 | 5,681 | $52.49 | $298.2K | 1,802 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-11-06 | 2013-11-08 | 1,802 | $53.61 | $96.6K | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-11-06 | 2013-11-08 | 28,394 | $50.60 | $1.44M | 21,606 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2013-11-06 | 2013-11-08 | 50,000 | $10.81 | $540.5K | 50,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2013-09-25 | 2013-09-27 | 10,000 | — | $0 | 8,349 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2013-09-25 | 2013-09-27 | 10,000 | $5.49 | $54.9K | 10,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-09-25 | 2013-09-27 | 10,000 | $47.00 | $470.0K | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2013-08-14 | 2013-08-16 | 14,700 | — | $0 | 6,685 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2013-08-14 | 2013-08-16 | 14,700 | $1.61 | $23.7K | 14,700 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-08-14 | 2013-08-16 | 14,700 | $37.00 | $543.9K | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2013-07-12 | 2013-07-15 | 29,754 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-07-12 | 2013-07-15 | 29,754 | $32.00 | $952.1K | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2013-07-12 | 2013-07-15 | 29,754 | $1.61 | $47.9K | 29,754 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2012-06-05 | 2012-06-07 | 150,000 | — | $0 | 150,000 | SEC↗ |